1,5-Anhydroglucitol and Postprandial Hyperglycemia as Measured by Continuous Glucose Monitoring System in Moderately Controlled Patients With Diabetes

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

1993 • 23,535 citations

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

1998 • 19,638 citations

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

1998 • 7,971 citations

Tests for comparing elements of a correlation matrix.

1980 • 4,226 citations

Contributions of Fasting and Postprandial Plasma Glucose Increments to the Overall Diurnal Hyperglycemia of Type 2 Diabetic Patients

2003 • 1,441 citations

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

1996 • 899 citations

Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level.

2000 • 546 citations

Stereotyping: From prejudice to prediction.

1980 • 314 citations

Performance Evaluation of the MiniMed® Continuous Glucose Monitoring System During Patient Home Use

2000 • 299 citations

Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study.

2000 • 249 citations

Continuous Subcutaneous Glucose Monitoring in Children With Type 1 Diabetes

2001 • 197 citations

Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body

1992 • 158 citations

Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control

1996 • 150 citations

Performance assessment of the Medtronic‐MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in Type 1 diabetic subjects

2003 • 144 citations

Circulating 1,5-Anhydroglucitol Levels in Adult Patients With Diabetes Reflect Longitudinal Changes of Glycemia

2004 • 137 citations

Reproducibility of Glucose Measurements Using the Glucose Sensor

2002 • 137 citations

Plasma 1,5-Anhydro-D-Glucitol as New Clinical Marker of Glycemic Control in NIDDM Patients

1989 • 135 citations

Serum 1,5-anhydroglucitol (1,5 AG): New clinical marker for glycemic control

1994 • 114 citations

Accuracy of the Modified Continuous Glucose Monitoring (CGMS^®) Sensor in an Outpatient Setting: Results from a Diabetes Research in Children Network (DirecNet) Study

2005 • 86 citations

The Glucose Area Under the Profiles Obtained With Continuous Glucose Monitoring System Relationships With HbAlc in Pediatric Type 1 Diabetic Patients

2002 • 86 citations

Postchallenge Hyperglycemia in a National Sample of U.S. Adults With Type 2 Diabetes

2001 • 85 citations

1,5-Anhydro-D-glucitol Evaluates Daily Glycemic Excursions in Well-Controlled NIDDM

1995 • 77 citations

Reduction and Recovery of Plasma 1,5-Anhydro-D-Glucitol Level in Diabetes Mellitus

1987 • 73 citations

Fully enzymatic method for determining 1,5-anhydro-D-glucitol in serum

1994 • 62 citations

Estimation of plasma glucose fluctuation with a combination test of hemoglobin A1c and 1,5-anhydroglucitol

1992 • 54 citations

Plasma 1,5‐anhydroglucitol concentrations are influenced by variations in the renal threshold for glucose

1999 • 45 citations

Plasma 1,5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients

1989 • 44 citations

Reduction and recovery of plasma 1,5-anhydro-D-glucitol level in diabetes mellitus

1987 • 19 citations